Advertisement

Consensus guidance of nebulizer therapy for acute rhinosinusitis

Published:August 31, 2019DOI:https://doi.org/10.1016/j.anl.2019.08.007

      Abstract

      The guidance deals with the recommended applications, procedures, and safety management of nebulizer therapy for acute rhinosinusitis. In Japan, nebulizer therapy for sinusitis has been covered by public health insurance since 1958 and has been commonly carried out nationwide. The Japan Society for Infection and Aerosol in Otorhinolaryngology and the Oto-Rhino-Laryngological Society of Japan set up a working group to draw up a consensus guidance on nebulizer therapy for acute rhinosinusitis.
      The device for nebulizer therapy are classified into jet, ultrasound, and mesh types. In Japan, cefmenoxime hydrochloride (CMX) was approved for use in nebulizer therapy since 1996. The widening of the obstructed lesions such as large polyps prior to nebulizer therapy were recommended. The numbers of times of nebulizer therapy is recommended for three times in a week for at least for 2 weeks (cure rate: 68%, eradication ratio: 48%). Concerns should be pay for the changes of activity of medicine due to the mixing and bacterial contamination. Pseudomonas cepacia growing in a short even in both saline and distilled water leads to contamination at high concentrations by 2 days.
      Nebulizer therapy is an effective treatment based on a drug delivery system (DDS) to the nasal and paranasal cavities. The therapy effectively increases the local drug concentration by promptly and uniformly delivering drugs to a targeted local site. The therapy is safe with less systemic absorption and with few adverse reactions.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Yamanaka N.
        • Iino Y.
        • Uno Y.
        • Kudo F.
        • Kurono Y.
        • Suzaki H.
        • et al.
        Practical guideline for management of acute rhinosinusitis in Japan.
        Auris Nasus Larynx. 2015; 42: 1-7
        • Japanese Rhinologic Society
        Guideline for management of acute rhinosinusitis.
        Nihon Bika Gakkai Kaishi. 2014; 53: 103-160
        • Barach A.L.
        • Garthwaite B.
        • Rule C.
        • Comdr L.
        • Talbot Jr, T.R.
        • Kernan J.D.
        • et al.
        Penicillin aerosol and negative pressure in the treatment of sinusitis.
        Am J Med. 1946; 1: 268-290
        • Desrosiers M.Y.
        • Salas-Prato M.
        Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotic therapy delivered by means of a large-particle nebulizer: results of a controlled trial.
        Otolaryngol Head Neck Surg. 2001; 125: 265-269
        • Takano N.
        • Ohki M.
        • Ogoshi T.
        • Itoh M.
        Choice and practice of therapeutic medical devices in otorhinolaryngology.
        Jibiinkoka Tembo. 2012; 55: 32-39
        • Hyo N.
        • Takano H.
        • Hyo Y.
        Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus.
        Rhinology. 1989; 27: 17-26
        • Saijo R.
        • Majima Y.
        • Hyo N.
        • Takano H.
        Particle deposition of therapeutic aerosols in the nose and paranasal sinuses after transnasal sinus surgery: a cast model study.
        Am J Rhinol. 2004; 18: 1-7
        • Lim M.
        • Citardi M.
        • Leong J.L.
        Topical antimicrobials in the management of chronic rhinosinusitis: a systemic reviews.
        Am J Rhinol. 2008; 22: 381-389
        • Haruna S.
        Postoperative aerosol therapy for chronic sinusitis.
        Jibiinkoka Tembo. 2002; 45 ([in Japanese]): 36-40
        • Yamada T.
        • Saito H.
        • Fujieda S.
        • Mori S.
        • Kimura Y.
        • Noda I.
        • et al.
        Efficacy of treatment to clean and widen the middle nasal meatus on rhinosinusitis.
        Oto Rhino Laryngol Clin. 2002; 95: 2153-2157
        • Baba S.
        • Suzuki K.
        • Miyamoto N.
        • Yokota A.
        • Kobayashi T.
        • Deguchi K.
        Concentration of CMX in the maxillary sinus after nebulization.
        Oto Rhino Laryngol Clin. 1996; 89: 1521-1524
        • Work group of the French Society of Otorhinolaryngology (SFORL)
        Consensus document for prescription of nebulization in rhinology.
        Eur Ann Otorhinolaryngol Head Neck Dis. 2014; 131: 371-374
        • Suzaki H.
        Efficacy of aerosol therapy with a nebulizer for the upper airway.
        Jibiinkoka Tembo. 2011; 54: 9-16
        • Naruto R.
        • Fujisawa T.
        • Nakasima M.
        • Suzuki K.
        Concentration of cefmenoxime hydrochloride (CMX) in the maxillary sinus after double compressor nebulization.
        Jibiinkoka Temno. 2008; 51: 11-14
        • Vaughan W.C.
        • Carvalho G.
        Use of nebulized antibiotics for acute infections in chronic sinusitis.
        Otolaryngol Head Neck Surg. 2002; 127: 558-568
        • Scheinberg P.A.
        • Otsuji A.
        Nebulized antibiotics for the treatment of acute exa- cerbations of chronic rhinosinusitis.
        Ear Nose Throat J. 2002; 81: 648-652
        • Videler W.J.
        • van Drunen C.M.
        • Reitsma J.B.
        • Fokkens W.J.
        Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study.
        Rhinology. 2008; 46: 92-98
        • Yoshiyama Y.
        Pharmaceutical care for aerosolized nebulizer therapy.
        Jibiinkoka Tembo. 2012; 55: 140-143
        • Baba S.
        • Endo S.
        • Kawamura S.
        • Ichikawa G.
        • Watanabe H.
        • Itahashi T.
        • et al.
        Evaluation of the efficacy of cefmenoxime (CMX) nebulization therapy in sinusitis.
        Jibi Rinsho. 1991; 37: 851-880
        • Fujihara K.
        • Sakai A.
        • Hotomi M.
        • Yamanaka N.
        The effectiveness of nasal nebulizer therapy with cefmenoxime hydrochloride and nasal drops of povidone iodine for acute rhinosinusitis in children.
        Oto Rhino Laryngol Clin. 2003; 97: 599-604
        • Baba S.
        • Miyamoto N.
        • Unno T.
        • Hokunan K.
        • Togawa K.
        • Yamanaka K.
        • et al.
        A clinical evaluation of nasal Fosfomycin (FOM) of paranasal sinusitis.
        Jibi Rinsho. 1995; 41: 238-254
        • Kamijyo A.
        • Kamijyo A.
        • Matsuzaki Z.
        • Kikushima K.
        • Ogino J.
        • Nozawa I.
        • et al.
        Fosfomycin nebulizer therapy to chronic sinusitis.
        Auris Nasal Larynx. 2001; 28: 227-232
        • Suzuki K.
        A randomized controlled study of paranasal sinusitis aerosol therapy (cefmenoxime + steroid) vs oral resolutional enzyme.
        Jibiinkoka Tembo. 2002; 45: 17-20
        • Takigawa K.
        • Fujita J.
        • Negayama K.
        • Yamagishi Y.
        • Yamaji Y.
        • Ouchi K.
        • et al.
        Nosocomial outbreak of Pseudomonas cepasia respiratory infection in immunocompromised patients associated with contaminated nebulizer devices.
        Kansenshogaku Zasshi. 1993; 67: 1115-1125
        • Ogoshi O.
        • Oki M.
        • Mochigi M.
        Microbiologic contamination study of nebulizer drug solution.
        Jibiinkoka Tembo. 2006; 49: 51-56
        • Mochigi M.
        • Oki M.
        • Yamaguchi S.
        • Okubo H.
        • Ogoshi T.
        Usefulness of an anti-reflux valve in ultrasonic nebulize.
        Japanese J Rhinol. 2007; 46: 11-17
        • Ganer J.S.
        • Favero M.S.
        Guideline for handwashing and hospital environmental control 1985.
        Am J Infect Control. 1986; 14: 110-129